PubRank

Michael J Lynn

Author PubWeight™ 113.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011 12.76
2 Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 7.92
3 Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006 4.21
4 A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year. Arch Ophthalmol 2010 4.12
5 Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years. JAMA Ophthalmol 2014 3.88
6 Risk assessment for ectasia after corneal refractive surgery. Ophthalmology 2007 3.47
7 The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol 2010 3.21
8 Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis 2011 2.70
9 Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol 2011 2.62
10 The resident surgeon phacoemulsification learning curve. Arch Ophthalmol 2007 2.57
11 Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007 2.50
12 Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology 2011 2.49
13 Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 2002 2.22
14 Long-term risk of glaucoma after congenital cataract surgery. Am J Ophthalmol 2013 2.22
15 Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Am J Ophthalmol 2013 2.20
16 Congruency in homonymous hemianopia. Am J Ophthalmol 2007 2.17
17 One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology 2013 2.00
18 Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012 1.91
19 Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke 2007 1.81
20 Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea 2008 1.68
21 Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes 2012 1.63
22 Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery 2013 1.58
23 Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009 1.54
24 Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis 2014 1.51
25 Is there a latent period for the surgical treatment of children with dense bilateral congenital cataracts? J AAPOS 2006 1.48
26 Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg 2012 1.45
27 Infant Aphakia Treatment Study: effects of persistent fetal vasculature on outcome at 1 year of age. J AAPOS 2011 1.40
28 The Infant Aphakia Treatment Study: evaluation of cataract morphology in eyes with monocular cataracts. J AAPOS 2011 1.32
29 Clinical outcome of confluent laser photoablation for retinopathy of prematurity. J AAPOS 2002 1.32
30 Glaucoma-related adverse events in the Infant Aphakia Treatment Study: 1-year results. Arch Ophthalmol 2011 1.25
31 Vitreous hemorrhage in children. Ophthalmology 2006 1.21
32 Homonymous hemianopia in stroke. J Neuroophthalmol 2006 1.17
33 Vitamin D insufficiency in diabetic retinopathy. Endocr Pract 2012 1.15
34 Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 2008 1.11
35 Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab 2010 1.08
36 Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. J Neuroimaging 2014 1.08
37 Visual rehabilitation and outcomes for ectasia after corneal refractive surgery. J Cataract Refract Surg 2008 1.05
38 Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 2006 1.05
39 Risk factors associated with severity and location of intracranial arterial stenosis. Stroke 2010 1.05
40 Incidence, outcomes, and risk factors for retreatment after wavefront-optimized ablations with PRK and LASIK. J Refract Surg 2009 1.05
41 Axial elongation following cataract surgery during the first year of life in the infant Aphakia Treatment Study. Invest Ophthalmol Vis Sci 2012 1.05
42 Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol 2008 1.03
43 Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study. Arch Ophthalmol 2012 1.00
44 The handy eye chart: a new visual acuity test for use in children. Ophthalmology 2012 1.00
45 Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke 2008 0.97
46 Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 2002 0.95
47 Visual outcome following the reduction or cessation of patching therapy after early unilateral cataract surgery. Arch Ophthalmol 2008 0.94
48 Outcomes of wavefront-optimized surface ablation. Ophthalmology 2007 0.92
49 Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke 2012 0.90
50 Serum insulin-like growth factor-I in diabetic retinopathy. Mol Vis 2011 0.89
51 Associations of plasma-soluble fas ligand with aging and age-related macular degeneration. Invest Ophthalmol Vis Sci 2008 0.87
52 Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial. Arch Ophthalmol 2012 0.87
53 Surgical outcomes with 360-degree suture trabeculotomy in poor-prognosis primary congenital glaucoma and glaucoma associated with congenital anomalies or cataract surgery. J AAPOS 2011 0.86
54 Blade source effect on laser in situ keratomileusis flap thickness with the Amadeus I microkeratome. J Cataract Refract Surg 2008 0.85
55 Surgical management of glaucoma in infants and children with Peters' anomaly: long-term structural and functional outcome. Ophthalmology 2004 0.85
56 Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis 2014 0.83
57 Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis. Cerebrovasc Dis 2011 0.81
58 Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis 2007 0.81
59 Pediatric homonymous hemianopia. J AAPOS 2006 0.81
60 Partial coherence interferometry versus immersion ultrasonography for axial length measurement in children. J Cataract Refract Surg 2010 0.80
61 Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads. Mol Vis 2009 0.79
62 A Comparison of Sequential Glaucoma Drainage Device Implantation Versus Cyclophotocoagulation Following Failure of a Primary Drainage Device. J Glaucoma 2016 0.78
63 Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz. Stroke 2012 0.78
64 A comparison of 2 methods for estimating residual stromal bed thickness before repeat LASIK. Ophthalmology 2005 0.77
65 Risk factors for epithelial defect formation during laser in situ keratomileusis. J Cataract Refract Surg 2007 0.77
66 Intracranial stenting: SAMMPRIS. Stroke 2013 0.76
67 Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis 2007 0.75
68 Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis 2016 0.75